SANDERS MACHELLE 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Jun 15, 2023
Insider Transaction Report
Form 4
SANDERS MACHELLE
Director
Transactions
- Award
Common Stock
2023-06-13+16,745→ 29,611 total - Sale
Common Stock
2023-06-15$7.98/sh−4,000$31,920→ 25,611 total - Award
Automatic Stock Option Grant
2023-06-13+39,072→ 39,072 totalExercise: $8.18From: 2024-06-13Exp: 2033-06-13→ Common Stock (39,072 underlying)
Footnotes (2)
- [F1]Automatic non-employee director grant of Restricted Stock Units pursuant to the BioCryst Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (the "Director Compensation Policy"), which will vest on the first anniversary of the date of grant.
- [F2]Automatic non-employee director grant of stock options pursuant to the Director Compensation Policy.